APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Anthelmintic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Albendazole Anthelmintic Drug Industry Growth and Trends Forecast to 2032

2 January 2026100 pages

Choose your research edition.

Industry ResearchAlbendazole Anthelmintic Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Anthelmintic Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albendazole Anthelmintic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Anthelmintic Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Anthelmintic Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Albendazole Anthelmintic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Albendazole Anthelmintic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Albendazole Anthelmintic Drug include Jiangsu Qihui, Huazhong Pharmaceutical, GlaxoSmithKline, Zhongjia Pharmaceutical, Supharma Chem, Sequent Scientific, Salius Pharma, Lasa Supergenerics Limited and K.A. Malle Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Albendazole Anthelmintic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Albendazole Anthelmintic Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Albendazole Anthelmintic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Albendazole Anthelmintic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Albendazole Anthelmintic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Albendazole Anthelmintic Drug Market by Company

Jiangsu Qihui

Huazhong Pharmaceutical

GlaxoSmithKline

Zhongjia Pharmaceutical

Supharma Chem

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

Fredun Pharmaceuticals Ltd

Albendazole Anthelmintic Drug Segment by Type

Tablet

Capsule

Other

Albendazole Anthelmintic Drug Segment by Application

Human

Veterinary

Albendazole Anthelmintic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Anthelmintic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Anthelmintic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Anthelmintic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albendazole Anthelmintic Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Albendazole Anthelmintic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Major Company of Other Table 4. Global Albendazole Anthelmintic Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Albendazole Anthelmintic Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Albendazole Anthelmintic Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Albendazole Anthelmintic Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Albendazole Anthelmintic Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Albendazole Anthelmintic Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Albendazole Anthelmintic Drug Industry Trends Table 26. Albendazole Anthelmintic Drug Industry Drivers Table 27. Albendazole Anthelmintic Drug Industry Opportunities and Challenges Table 28. Albendazole Anthelmintic Drug Industry Restraints Table 29. Global Albendazole Anthelmintic Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Albendazole Anthelmintic Drug Revenue Market Share by Company (2021-2026) Table 31. Global Albendazole Anthelmintic Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Albendazole Anthelmintic Drug Sales Share by Company (2021-2026) Table 33. Global Albendazole Anthelmintic Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Albendazole Anthelmintic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Albendazole Anthelmintic Drug Major Company Production Sites and Headquarters Table 36. Global Albendazole Anthelmintic Drug Company, Product Type & Application Table 37. Global Albendazole Anthelmintic Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Albendazole Anthelmintic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Albendazole Anthelmintic Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Albendazole Anthelmintic Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Albendazole Anthelmintic Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Albendazole Anthelmintic Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Albendazole Anthelmintic Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Albendazole Anthelmintic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Albendazole Anthelmintic Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Albendazole Anthelmintic Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Albendazole Anthelmintic Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Albendazole Anthelmintic Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Albendazole Anthelmintic Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Albendazole Anthelmintic Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Albendazole Anthelmintic Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Albendazole Anthelmintic Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Jiangsu Qihui Company Information Table 73. Jiangsu Qihui Business Overview Table 74. Jiangsu Qihui Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio Table 76. Jiangsu Qihui Recent Development Table 77. Huazhong Pharmaceutical Company Information Table 78. Huazhong Pharmaceutical Business Overview Table 79. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 81. Huazhong Pharmaceutical Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Zhongjia Pharmaceutical Company Information Table 88. Zhongjia Pharmaceutical Business Overview Table 89. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio Table 91. Zhongjia Pharmaceutical Recent Development Table 92. Supharma Chem Company Information Table 93. Supharma Chem Business Overview Table 94. Supharma Chem Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Supharma Chem Albendazole Anthelmintic Drug Product Portfolio Table 96. Supharma Chem Recent Development Table 97. Sequent Scientific Company Information Table 98. Sequent Scientific Business Overview Table 99. Sequent Scientific Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio Table 101. Sequent Scientific Recent Development Table 102. Salius Pharma Company Information Table 103. Salius Pharma Business Overview Table 104. Salius Pharma Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Salius Pharma Albendazole Anthelmintic Drug Product Portfolio Table 106. Salius Pharma Recent Development Table 107. Lasa Supergenerics Limited Company Information Table 108. Lasa Supergenerics Limited Business Overview Table 109. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio Table 111. Lasa Supergenerics Limited Recent Development Table 112. K.A. Malle Pharmaceuticals Company Information Table 113. K.A. Malle Pharmaceuticals Business Overview Table 114. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio Table 116. K.A. Malle Pharmaceuticals Recent Development Table 117. Fredun Pharmaceuticals Ltd Company Information Table 118. Fredun Pharmaceuticals Ltd Business Overview Table 119. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio Table 121. Fredun Pharmaceuticals Ltd Recent Development Table 122. North America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 124. North America Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 125. North America Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Albendazole Anthelmintic Drug Sales Market Share Forecast by Country (2027-2032) Table 127. North America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Albendazole Anthelmintic Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Albendazole Anthelmintic Drug Market Share by Country (2021-2026) Table 130. North America Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Albendazole Anthelmintic Drug Market Share Forecast by Country (2027-2032) Table 132. Europe Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 134. Europe Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 135. Europe Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Albendazole Anthelmintic Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Albendazole Anthelmintic Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Albendazole Anthelmintic Drug Market Share by Country (2021-2026) Table 140. Europe Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Albendazole Anthelmintic Drug Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Albendazole Anthelmintic Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Albendazole Anthelmintic Drug Market Share by Country (2021-2026) Table 150. Asia-Pacific Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Albendazole Anthelmintic Drug Market Share Forecast by Country (2027-2032) Table 152. Latin America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 154. Latin America Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 155. Latin America Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Albendazole Anthelmintic Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Albendazole Anthelmintic Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Albendazole Anthelmintic Drug Market Share by Country (2021-2026) Table 160. Latin America Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Albendazole Anthelmintic Drug Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Albendazole Anthelmintic Drug Market Share by Country (2021-2026) Table 170. Middle East and Africa Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Albendazole Anthelmintic Drug Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Albendazole Anthelmintic Drug Distributors List Table 175. Albendazole Anthelmintic Drug Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Albendazole Anthelmintic Drug Image Figure 2. Global Albendazole Anthelmintic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Anthelmintic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Albendazole Anthelmintic Drug Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Albendazole Anthelmintic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Albendazole Anthelmintic Drug Market Share by Type 2025 VS 2032 Figure 13. North America Albendazole Anthelmintic Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Albendazole Anthelmintic Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Albendazole Anthelmintic Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Albendazole Anthelmintic Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Albendazole Anthelmintic Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Albendazole Anthelmintic Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Albendazole Anthelmintic Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Image Figure 26. Global Human Sales YoY Growth (2021-2032) & (K Units) Figure 27. Veterinary Image Figure 28. Global Veterinary Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Albendazole Anthelmintic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Albendazole Anthelmintic Drug Market Share by Application 2025 VS 2032 Figure 31. North America Albendazole Anthelmintic Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Albendazole Anthelmintic Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Albendazole Anthelmintic Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Albendazole Anthelmintic Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Albendazole Anthelmintic Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Albendazole Anthelmintic Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Albendazole Anthelmintic Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Albendazole Anthelmintic Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Albendazole Anthelmintic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Albendazole Anthelmintic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Albendazole Anthelmintic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Albendazole Anthelmintic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Albendazole Anthelmintic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Albendazole Anthelmintic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Albendazole Anthelmintic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Albendazole Anthelmintic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Albendazole Anthelmintic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Albendazole Anthelmintic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Albendazole Anthelmintic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Albendazole Anthelmintic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Albendazole Anthelmintic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Albendazole Anthelmintic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Albendazole Anthelmintic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Albendazole Anthelmintic Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Albendazole Anthelmintic Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • Jiangsu Qihui
  • Huazhong Pharmaceutical
  • GlaxoSmithKline
  • Zhongjia Pharmaceutical
  • Supharma Chem
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • Fredun Pharmaceuticals Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albendazole Anthelmintic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Albendazole Anthelmintic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Albendazole Anthelmintic Drug Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.3.3 Other
  9. 1.4 Global Albendazole Anthelmintic Drug Market Size by Type
  10. 1.4.1 Global Albendazole Anthelmintic Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Albendazole Anthelmintic Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Albendazole Anthelmintic Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Albendazole Anthelmintic Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Albendazole Anthelmintic Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Albendazole Anthelmintic Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Albendazole Anthelmintic Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Albendazole Anthelmintic Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Albendazole Anthelmintic Drug Industry Trends
  2. 2.2 Albendazole Anthelmintic Drug Industry Drivers
  3. 2.3 Albendazole Anthelmintic Drug Industry Opportunities and Challenges
  4. 2.4 Albendazole Anthelmintic Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Albendazole Anthelmintic Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Albendazole Anthelmintic Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Albendazole Anthelmintic Drug Price (2021-2026)
  4. 3.4 Global Albendazole Anthelmintic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albendazole Anthelmintic Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Albendazole Anthelmintic Drug Company, Product Type & Application
  7. 3.7 Global Albendazole Anthelmintic Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albendazole Anthelmintic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albendazole Anthelmintic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albendazole Anthelmintic Drug Tier 1, Tier 2, and Tier 3
4 Albendazole Anthelmintic Drug Regional Status and Outlook
  1. 4.1 Global Albendazole Anthelmintic Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Albendazole Anthelmintic Drug Historic Market Size by Region
  3. 4.2.1 Global Albendazole Anthelmintic Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Albendazole Anthelmintic Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Albendazole Anthelmintic Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Albendazole Anthelmintic Drug Forecasted Market Size by Region
  7. 4.3.1 Global Albendazole Anthelmintic Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Albendazole Anthelmintic Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Albendazole Anthelmintic Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Albendazole Anthelmintic Drug by Application
  1. 5.1 Albendazole Anthelmintic Drug Market by Application
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Albendazole Anthelmintic Drug Market Size by Application
  5. 5.2.1 Global Albendazole Anthelmintic Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Albendazole Anthelmintic Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Albendazole Anthelmintic Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Albendazole Anthelmintic Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Albendazole Anthelmintic Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Albendazole Anthelmintic Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Albendazole Anthelmintic Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Albendazole Anthelmintic Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jiangsu Qihui
  2. 6.1.1 Jiangsu Qihui Company Information
  3. 6.1.2 Jiangsu Qihui Business Overview
  4. 6.1.3 Jiangsu Qihui Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jiangsu Qihui Albendazole Anthelmintic Drug Product Portfolio
  6. 6.1.5 Jiangsu Qihui Recent Developments
  7. 6.2 Huazhong Pharmaceutical
  8. 6.2.1 Huazhong Pharmaceutical Company Information
  9. 6.2.2 Huazhong Pharmaceutical Business Overview
  10. 6.2.3 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Huazhong Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  12. 6.2.5 Huazhong Pharmaceutical Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Albendazole Anthelmintic Drug Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Zhongjia Pharmaceutical
  20. 6.4.1 Zhongjia Pharmaceutical Company Information
  21. 6.4.2 Zhongjia Pharmaceutical Business Overview
  22. 6.4.3 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zhongjia Pharmaceutical Albendazole Anthelmintic Drug Product Portfolio
  24. 6.4.5 Zhongjia Pharmaceutical Recent Developments
  25. 6.5 Supharma Chem
  26. 6.5.1 Supharma Chem Company Information
  27. 6.5.2 Supharma Chem Business Overview
  28. 6.5.3 Supharma Chem Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Supharma Chem Albendazole Anthelmintic Drug Product Portfolio
  30. 6.5.5 Supharma Chem Recent Developments
  31. 6.6 Sequent Scientific
  32. 6.6.1 Sequent Scientific Company Information
  33. 6.6.2 Sequent Scientific Business Overview
  34. 6.6.3 Sequent Scientific Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sequent Scientific Albendazole Anthelmintic Drug Product Portfolio
  36. 6.6.5 Sequent Scientific Recent Developments
  37. 6.7 Salius Pharma
  38. 6.7.1 Salius Pharma Company Information
  39. 6.7.2 Salius Pharma Business Overview
  40. 6.7.3 Salius Pharma Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Salius Pharma Albendazole Anthelmintic Drug Product Portfolio
  42. 6.7.5 Salius Pharma Recent Developments
  43. 6.8 Lasa Supergenerics Limited
  44. 6.8.1 Lasa Supergenerics Limited Company Information
  45. 6.8.2 Lasa Supergenerics Limited Business Overview
  46. 6.8.3 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lasa Supergenerics Limited Albendazole Anthelmintic Drug Product Portfolio
  48. 6.8.5 Lasa Supergenerics Limited Recent Developments
  49. 6.9 K.A. Malle Pharmaceuticals
  50. 6.9.1 K.A. Malle Pharmaceuticals Company Information
  51. 6.9.2 K.A. Malle Pharmaceuticals Business Overview
  52. 6.9.3 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 K.A. Malle Pharmaceuticals Albendazole Anthelmintic Drug Product Portfolio
  54. 6.9.5 K.A. Malle Pharmaceuticals Recent Developments
  55. 6.10 Fredun Pharmaceuticals Ltd
  56. 6.10.1 Fredun Pharmaceuticals Ltd Company Information
  57. 6.10.2 Fredun Pharmaceuticals Ltd Business Overview
  58. 6.10.3 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fredun Pharmaceuticals Ltd Albendazole Anthelmintic Drug Product Portfolio
  60. 6.10.5 Fredun Pharmaceuticals Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Albendazole Anthelmintic Drug Sales by Country
  2. 7.1.1 North America Albendazole Anthelmintic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Albendazole Anthelmintic Drug Market Size by Country
  6. 7.2.1 North America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Albendazole Anthelmintic Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Albendazole Anthelmintic Drug Sales by Country
  2. 8.1.1 Europe Albendazole Anthelmintic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Albendazole Anthelmintic Drug Market Size by Country
  6. 8.2.1 Europe Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Albendazole Anthelmintic Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Albendazole Anthelmintic Drug Sales by Country
  2. 9.1.1 Asia-Pacific Albendazole Anthelmintic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Albendazole Anthelmintic Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Albendazole Anthelmintic Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Albendazole Anthelmintic Drug Sales by Country
  2. 10.1.1 South America Albendazole Anthelmintic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Albendazole Anthelmintic Drug Market Size by Country
  6. 10.2.1 South America Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Albendazole Anthelmintic Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Albendazole Anthelmintic Drug Sales by Country
  2. 11.1.1 Middle East and Africa Albendazole Anthelmintic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Albendazole Anthelmintic Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Albendazole Anthelmintic Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Albendazole Anthelmintic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Albendazole Anthelmintic Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Albendazole Anthelmintic Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Albendazole Anthelmintic Drug Value Chain Analysis
  2. 12.1.1 Albendazole Anthelmintic Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Albendazole Anthelmintic Drug Production Mode & Process
  7. 12.2 Albendazole Anthelmintic Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Albendazole Anthelmintic Drug Distributors
  10. 12.2.3 Albendazole Anthelmintic Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst